All eyes on Bursa


Recovery, vaccination, politics to determine momentum

KUALA LUMPUR: The FBM KLCI’s performance this month will hinge on the country’s ability to maintain its high vaccination rate and accommodate quick economic recovery and growth.

CGS-CIMB Research in a strategy note yesterday said the market rally’s momentum in August can be sustained this month, if states with high infection rates can progress into the final phases of the National Recovery Plan (NRP) as quickly as possible.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Bursa Malaysia , FBM-KLCI , vaccination , politics

Next In Business News

Bank Negara international reserves at US$126.6bil as at March 31, 2026
Pharmaniaga proposes five-to-one share consolidation
Bursa Malaysia lower at midday as West Asia conflict continues
Meta Bright secures RM8.5mil AmBank facility for expansion of EV charging ports
Binastra, Eco-shop, Kelington among top companies for ESG investment in 2026 - RHB IB
Ekuinas acquires stake in country's leading local sterile pharmaceutical manufacturer
IJM shares down in early trade as Sunway's takeover attempt lapses
Stocks struggle, oil jumps as Trump's Iran deadline looms
Hong Leong launches new portfolio financing solution
FBM KLCI retraces slightly as Iran ceasefire discussions continue

Others Also Read